Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
DISHMAN PHARMA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DISHMAN PHARMA Mar-16 |
TEVA PHARMA Dec-13 |
DISHMAN PHARMA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 374 | 3,480 | - | |
Low | Rs | 129 | 3,023 | - | |
Sales per share (Unadj.) | Rs | 197.0 | 1,997.4 | - | |
Earnings per share (Unadj.) | Rs | 21.2 | 124.8 | - | |
Cash flow per share (Unadj.) | Rs | 34.7 | 286.2 | - | |
Dividends per share (Unadj.) | Rs | 2.00 | 109.23 | - | |
Avg Dividend yield | % | 0.8 | 3.4 | 23.7% | |
Book value per share (Unadj.) | Rs | 179.9 | 2,218.7 | - | |
Shares outstanding (eoy) | m | 80.70 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.3 | 1.6 | 78.5% | |
Avg P/E ratio | x | 11.9 | 26.1 | 45.6% | |
P/CF ratio (eoy) | x | 7.3 | 11.4 | 63.8% | |
Price / Book Value ratio | x | 1.4 | 1.5 | 95.5% | |
Dividend payout | % | 9.4 | 87.5 | 10.8% | |
Avg Mkt Cap | Rs m | 20,307 | 2,757,543 | 0.7% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 5,355 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,685.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,354.2 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 15,898 | 1,693,781 | 0.9% | |
Other income | Rs m | 265 | 0 | - | |
Total revenues | Rs m | 16,163 | 1,693,781 | 1.0% | |
Gross profit | Rs m | 4,103 | 463,843 | 0.9% | |
Depreciation | Rs m | 1,091 | 136,910 | 0.8% | |
Interest | Rs m | 944 | 33,269 | 2.8% | |
Profit before tax | Rs m | 2,334 | 293,664 | 0.8% | |
Minority Interest | Rs m | 0 | 1,334 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,775 | -0.0% | |
Tax | Rs m | 624 | -3,585 | -17.4% | |
Profit after tax | Rs m | 1,710 | 105,809 | 1.6% | |
Gross profit margin | % | 25.8 | 27.4 | 94.2% | |
Effective tax rate | % | 26.7 | -1.2 | -2,188.8% | |
Net profit margin | % | 10.8 | 6.2 | 172.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,018 | 1,143,974 | 1.0% | |
Current liabilities | Rs m | 9,517 | 997,642 | 1.0% | |
Net working cap to sales | % | 9.4 | 8.6 | 109.3% | |
Current ratio | x | 1.2 | 1.1 | 101.0% | |
Inventory Days | Days | 57 | 91 | 62.8% | |
Debtors Days | Days | 3 | 96 | 3.6% | |
Net fixed assets | Rs m | 18,787 | 553,226 | 3.4% | |
Share capital | Rs m | 161 | 4,169 | 3.9% | |
Net worth | Rs m | 14,516 | 1,881,470 | 0.8% | |
Long term debt | Rs m | 4,189 | 866,068 | 0.5% | |
Total assets | Rs m | 29,805 | 3,870,833 | 0.8% | |
Interest coverage | x | 3.5 | 9.8 | 35.3% | |
Debt to equity ratio | x | 0.3 | 0.5 | 62.7% | |
Sales to assets ratio | x | 0.5 | 0.4 | 121.9% | |
Return on assets | % | 8.9 | 3.6 | 247.9% | |
Return on equity | % | 11.8 | 5.6 | 209.5% | |
Return on capital | % | 17.5 | 4.9 | 355.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,786 | 269,901 | 1.0% | |
From Investments | Rs m | -1,529 | -95,637 | 1.6% | |
From Financial Activity | Rs m | -941 | -323,765 | 0.3% | |
Net Cashflow | Rs m | 317 | -149,500 | -0.2% |
Compare DISHMAN PHARMA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare DISHMAN PHARMA With: HESTER BIOSCIENCES CIAN HEALTHCARE AJANTA PHARMA ERIS LIFESCIENCES LACTOSE INDIA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.